MedPath

Comparing two drugs as adjuvants to local anaesthetic in patients of carcinoma cervix undergoing brachytherapy procedure

Not Applicable
Conditions
Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified
Registration Number
CTRI/2022/05/042677
Lead Sponsor
Homi Bhabha Cancer Hospital Research Centre Punjab
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Patients of carcinoma cervix posted for intracavitary brachytherapy

2)Written informed consent

Exclusion Criteria

1)Refused consent for spinal anaesthesia

2)Patients who need admission overnight

3)Any contraindications to spinal anaesthesia (including coagulopathy, low absolute neutrophil count, allergic to local anaesthetic)

4)Patients with raised intracranial pressure, peripheral neuropathy, demyelinating central nervous system disorders, local sepsis were excluded

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Comparing the absolute duration of spinal analgesia among the two groups.Timepoint: Over 12 hours post-spinal anaesthesia.
Secondary Outcome Measures
NameTimeMethod
1. VAS Pain Scores <br/ ><br>2. Quality of spinal anaesthesia <br/ ><br>3. Sedation Score <br/ ><br>4. Time to achieve hospital discharge criteria <br/ ><br>5. Patient Satisfaction ScoreTimepoint: 1.5-15 minutes during procedure after that every 30 minutes <br/ ><br>2. At the end of procedure <br/ ><br>3. 5-15 minutes during procedure after that every 30 minutes <br/ ><br>4. Every 30 minutes post procedure <br/ ><br>5. After 12 hrs post spinal anaesthesia.
© Copyright 2025. All Rights Reserved by MedPath